Literature DB >> 17300997

Mitochondrial dysfunction in Parkinson's disease.

Jiro Fukae1, Yoshikuni Mizuno, Nobutaka Hattori.   

Abstract

Parkinson's disease (PD) is one of the most common neurodegenerative disorders characterized by resting tremor, rigidity, and bradykinesia. The primary cause of PD is still unknown, but oxidative stress and mitochondrial dysfunction have been implicated as important contributors to neuronal death in substantia nigra (SN) of PD. Considering neurons as post-mitotic cells, neurons could have error-avoiding mechanism against oxidative DNA damage. Indeed, several DNA repairing enzymes such as MTH1, OGG1, and MUTYH express in human brain. All the three enzymes up-regulated in the SN of PD patients, suggesting these three enzymes cooperate in mitochondrial DNA repairing in PD brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17300997     DOI: 10.1016/j.mito.2006.12.002

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  34 in total

1.  The DNA polymerase gamma Y955C disease variant associated with PEO and parkinsonism mediates the incorporation and translesion synthesis opposite 7,8-dihydro-8-oxo-2'-deoxyguanosine.

Authors:  Maria A Graziewicz; Rachelle J Bienstock; William C Copeland
Journal:  Hum Mol Genet       Date:  2007-08-27       Impact factor: 6.150

Review 2.  DNA damage and repair: relevance to mechanisms of neurodegeneration.

Authors:  Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

Review 3.  Parkin and PINK1 functions in oxidative stress and neurodegeneration.

Authors:  Sandeep K Barodia; Rose B Creed; Matthew S Goldberg
Journal:  Brain Res Bull       Date:  2016-12-23       Impact factor: 4.077

4.  Global stress response in a prokaryotic model of DJ-1-associated Parkinsonism.

Authors:  Nadia Messaoudi; Valérie Gautier; Fatoum Kthiri; Gaelle Lelandais; Mouadh Mihoub; Danièle Joseleau-Petit; Teresa Caldas; Chantal Bohn; Leah Tolosa; Govind Rao; Kazuyuki Tao; Ahmed Landoulsi; Philippe Bouloc; Gilbert Richarme
Journal:  J Bacteriol       Date:  2013-01-04       Impact factor: 3.490

5.  LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: implications for mitochondrial dysfunction associated with Parkinson's disease.

Authors:  Yulia Y Tyurina; Daniel E Winnica; Valentina I Kapralova; Alexandr A Kapralov; Vladimir A Tyurin; Valerian E Kagan
Journal:  Mol Nutr Food Res       Date:  2013-05-03       Impact factor: 5.914

Review 6.  Photobiomodulation as a treatment for neurodegenerative disorders: current and future trends.

Authors:  Namgue Hong
Journal:  Biomed Eng Lett       Date:  2019-06-12

7.  Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase.

Authors:  Sally A Madsen-Bouterse; Qing Zhong; Ghulam Mohammad; Ye-Shih Ho; Renu A Kowluru
Journal:  Free Radic Res       Date:  2010-03

8.  Ogg1 null mice exhibit age-associated loss of the nigrostriatal pathway and increased sensitivity to MPTP.

Authors:  Fernando Cardozo-Pelaez; Monica Sanchez-Contreras; Andrew B C Nevin
Journal:  Neurochem Int       Date:  2012-06-26       Impact factor: 3.921

9.  Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease.

Authors:  Renata Pietsch Ribeiro; Eduardo Luiz Gasnhar Moreira; Danúbia Bonfanti Santos; Dirleise Colle; Alessandra Antunes Dos Santos; Kaite Cristiane Peres; Claudia Pinto Figueiredo; Marcelo Farina
Journal:  Neurochem Res       Date:  2013-01-19       Impact factor: 3.996

10.  Betaine protects against rotenone-induced neurotoxicity in PC12 cells.

Authors:  A-Rang Im; Young-Hwa Kim; Md Romij Uddin; Sungwook Chae; Hye Won Lee; Yun Hee Kim; Yeong Shik Kim; Mi-Young Lee
Journal:  Cell Mol Neurobiol       Date:  2013-04-20       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.